| Literature DB >> 24198736 |
Dinesh Kumar1, Silky Chadda, Jyoti Sharma, Parveen Surain.
Abstract
An EtOH solution ofEntities:
Year: 2013 PMID: 24198736 PMCID: PMC3808720 DOI: 10.1155/2013/981764
Source DB: PubMed Journal: Bioinorg Chem Appl Impact factor: 7.778
Analytical, colour, molar conductance (Ω−1 cm2 mol−1), mass spectral, and molecular weight data of compounds.
| S. no. | Compound | Stoichiometry | Colour | Yield | ΛM (Ω−1 cm2 mol−1) | Found (calcd) | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| M. Wt. | M% | C% | H% | N% | ||||||
| (1) |
| C11H14N4O3 | Yellow | 22.5 (90) | — | 250.1a (250) | — | 52.69 (52.80) | 5.71 (5.60) | 22.36 (22.40) |
| (2) |
| MnC14H24N4O6 | Grey | 1.14 (57) | 11.7 | 352.6b (398.9) | 13.63 (13.76) | 42.08 (42.12) | 6.11 (6.02) | 14.17 (14.04) |
| (3) |
| CoC14H24N4O6 | Brown | 1.25 (62) | 10.3 | 423.4b (402.9) | 14.43 (14.62) | 41.82 (41.70) | 5.88 (5.96) | 13.72 (13.90) |
| (4) |
| NiC14H24N4O6 | Purple | 1.37 (68) | 9.2 | 392.6b (402.7) | 14.67 (14.58) | 41.79 (41.72) | 5.87 (5.96) | 13.73 (13.91) |
| (5) |
| Cu2C22H24N8O6 | Dark Green | 1.12 (72) | 6.8 | 618.4b (623.0) | 20.52 (20.39) | 42.46 (42.38) | 3.73 (3.85) | 17.82 (17.98) |
| (6) |
| ZnC12H16N4O4 | Yellow | 0.86 (50) | 5.6 | 363.9b (345.4) | 18.65 (18.93) | 41.52 (41.69) | 4.73 (4.63) | 16.08 (16.21) |
| (7) |
| CdC12H16N4O4 | White | 1.18 (60) | 5.2 | 387.3b (392.4) | 28.52 (28.64) | 36.82 (36.70) | 4.13 (4.08) | 14.31 (14.27) |
| (8) |
| ZrC13H22N4O7 | Yellow | 1.64 (75) | 5.0 | 425.8b (437.2) | 20.93 (20.86) | 35.63 (35.68) | 5.08 (5.03) | 12.72 (12.81) |
| (9) |
| MoC12H16N4O6 | Yellow | 1.18 (58) | 4.7 | 419.6b (407.9) | 23.48 (23.51) | 35.23 (35.30) | 3.84 (3.92) | 13.52 (13.73) |
| (10) |
| UC12H16N4O6 | Orange | 1.79 (65) | 3.6 | 541.7b (550.0) | 43.44 (43.27) | 26.36 (26.18) | 2.88 (2.91) | 10.02 (10.18) |
Abbreviations: amass spectral data and bRast method data.
NMR spectral data of the coordination compounds.
| S. no. | Compound | Stoichiometry |
1H NMR (400 MHz; DMSO-d6) |
|---|---|---|---|
| (1) |
| ZnC12H16N4O4 | 1.27 (t, 3H, –CH3), 2.06 (s, 3H, –CH3) (MeOH), |
| (2) |
| CdC12H16N4O4 | 1.25 (t, 3H, –CH3), 2.15 (s, 3H, –CH3) (MeOH), |
| (3) |
| ZrC13H22N4O7 | 1.30 (t, 3H, –CH3), 2.15 (s, 3H, –CH3) (MeOH), 2.50 (s, 3H, –CH3) (MeOH), 2.58 (s, 1H, –CH), 3.16 (br, 2H, –OH), 3.26 (br, 2H, –OH) (MeOH), 5.14 (d, 2H, –NH2), 6.74–7.88 (m, 4H, Ar–H), 8.72 (br, 1H, –NH), 9.87 (br, 1H, –OH) (phenolic) |
| (4) |
| MoC12H16N4O6 | 1.25 (t, 3H, –CH3), 2.25 (s, 3H, –CH3) (MeOH), |
| (5) |
| UC12H16N4O6 | 1.25 (t, 3H, –CH3), 2.35 (s, 3H, –CH3) (MeOH), |
Scheme 1Synthesis of the Schiff base.
Scheme 2Synthesis of complexes 2-7.
IR, reflectance spectral data (cm−1), and magnetic moments of the coordination compounds.
| S. no. | Compound |
|
|
| Magnetic moment (B.M.) |
|---|---|---|---|---|---|
| (1) |
| 1619 | 1239 | — | — |
| (2) |
| 1604 | 1256 | 15860, 21275, 25850 | 5.86 |
| (3) |
| 1601 | 1247 | 9091, 13698, 19820 | 4.78 |
| (4) |
| 1605 | 1257 | 9250, 15360, 24095 | 3.17 |
| (5) |
| 1605 | 1248 | 14750, 20150 | 1.76 |
| (6) |
| 1606 | 1257 | — | Diamagnetic |
| (7) |
| 1608 | 1254 | — | Diamagnetic |
| (8) |
| 1612 | 1250 | — | Diamagnetic |
| (9) |
| 1598 | 1252 | — | Diamagnetic |
| (10) |
| 1595 | 1248 | — | Diamagnetic |
In vitro antimicrobial activity of synthetic chemical compounds through agar well diffusion method.
| Compound | Diameter of growth of inhibition zone (mm)a | |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
|
| 19.3 | 21.6 | — | — | — | — |
|
| — | — | — | — | 13.0 | 15.3 |
|
| 15.3 | 17.3 | — | — | — | — |
|
| 13.6 | 15.6 | — | — | — | — |
|
| 22.6 | 25.3 | 15.3 | — | — | — |
|
| 21.3 | 22.6 | 12.6 | — | — | — |
|
| 18.6 | 20.3 | — | — | — | — |
|
| 14.6 | 19.3 | — | — | — | — |
|
| 16.3 | 22.3 | — | — | — | — |
|
| 17.6 | 20.6 | — | — | — | — |
| Ciprofloxacin | 26.6 | 24.0 | 25.0 | 22.0 | — | — |
| Amphotericin B | — | — | — | — | 19.3 | 16.6 |
—: no activity, avalues, including diameter of the well (8 mm), are means of three replicates.
Minimum inhibitory concentration (MIC) (µg/mL) of compounds by using modified agar well diffusion method.
| Compound no. |
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
| 64 | 32 | — | — | — | — |
|
| — | — | — | — | 128 | 128 |
|
| 128 | 128 | — | — | — | — |
|
| 256 | 128 | — | — | — | — |
|
| 32 | 16 | 128 | — | — | — |
|
| 32 | 32 | 512 | — | — | — |
|
| 64 | 64 | — | — | — | — |
|
| 64 | 64 | — | — | — | — |
|
| 64 | 32 | — | — | — | — |
|
| 128 | 128 | — | — | — | — |
| Ciprofloxacin | 6.25 | 6.25 | 6.25 | 6.25 | — | — |
| Amphotericin B | — | — | — | — | 12.5 | 12.5 |
—: no activity.
Figure 1Bar Chart indicating the diameter of growth of inhibition zone for compounds/standard against various microbes.
Figure 2Bar Chart indicating minimum inhibitory concentration (MIC) (μg/mL) for compounds/standard against various microbes. Abbreviations: Sa: S. aureus, Bs: B. subtilis, Ec: E. coli, Pa: P. aeruginosa, Sc: S. cerevisiae, Ca: C. albicans.
Scheme 3